OS Therapies targets Sept. 2026 FDA OST-HER2 decision, voucher upside – Stock Titan

Published: 02/02/2026

tags

Latest News

NEWS 02.02.2026

The First Saudi Conference on Gynecology and Fertility Concludes in Jeddah – Voice Of HealthCare

NEWS 02.02.2026

Exosomes Market to Reach US$ 2659.79 Million by 2033 at 29.7% – openPR.com

NEWS 02.02.2026

Groundbreaking therapy for advanced heart failure – The Manila Times

NEWS 02.02.2026

Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative – Investing News Network